Actively Recruiting
Research for the Molecular Imaging of the HER2 Targeting Tracer
Led by Peking University Cancer Hospital & Institute · Updated on 2025-03-21
200
Participants Needed
1
Research Sites
311 weeks
Total Duration
On this page
Sponsors
P
Peking University Cancer Hospital & Institute
Lead Sponsor
T
The Affiliated Hospital of Qingdao University
Collaborating Sponsor
AI-Summary
What this Trial Is About
To use the molecular PET radionuclide (Ga-68 or F-18) labelled HER2 Affibody to detect the expression of HER2 in the primary and metastatic lesions in patients with HER2 positive or suspicious positive tumors; to detect the expression heterogeneity of HER2 in the lesions and inter-lesions; to observe the change of HER2 expression in the course of treatment. To provide an approach for screening patients high expression of HER2, efficacy monitoring, drug resistance and early warning of recurrence and metastasis to achieve the individualized antitumor treatment of targeted drugs.
CONDITIONS
Official Title
Research for the Molecular Imaging of the HER2 Targeting Tracer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged > 18 years old; ECOG 0 or 1
- Patients with HER2 positive or suspicious positive tumors
- Has at least one measurable target lesion according to CT or MRI
- Life expectancy 24 12 weeks
You will not qualify if you...
- Significant hepatic or renal dysfunction
- Is pregnant or ready to pregnant
- Cannot keep their states for half an hour
- Refused to join the clinical research
- Suffering from claustrophobia or other mental disorders
- Any other situation that researchers considered it unsuitable to participate in the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hua Zhu
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here